| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 09/30/2004 | US20040192954 Protected tyrosine derivatives, method for the production thereof and use of the same for producing o-(2-[18f]-fluoroethyl)-l-tyrosine |
| 09/30/2004 | US20040192944 14-Hydrido-9beta-hydroxytetracyclic taxanes |
| 09/30/2004 | US20040192771 Cerdiovascular disorders; antilipemic agents; alzheimer's disease; anticancer agents; sepsis; thrombosis; hypotensive agents; kidney diseases; antiinflammatory agents |
| 09/30/2004 | US20040192767 EP4 receptor antagonists |
| 09/30/2004 | US20040192766 Use of enantiomeric pure escitalopram |
| 09/30/2004 | US20040192765 Use of enantiomeric pure escitalopram |
| 09/30/2004 | US20040192764 Use of enantiomeric pure escitalopram |
| 09/30/2004 | US20040192758 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 09/30/2004 | US20040192757 Reacting a 2-pyrrolidinone with alpha-keto acid; cyclization, ammonolysis , catalytic hydrogenation |
| 09/30/2004 | US20040192744 Inhibition of Histone Deacetylase; antiproliferative; antitumor: cell differentiation; 3,5-Dimethyl-isoxazole-4-carboxylic acid (2-amino-4,5-dichloro-phenyl)-amide |
| 09/30/2004 | US20040192742 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; glomerulonephritis; malaria; oral diseases |
| 09/30/2004 | US20040192740 for treating or preventing conditions associated with altered mitochondrial function with such compounds eg Alzheimer's Disease; diabetes mellitus; obesity; Parkinson's Disease; Huntington's disease; dystonia; Leber's hereditary optic neuropathy |
| 09/30/2004 | US20040192693 Antidiabetic agents; arteriosclerosis; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents |
| 09/30/2004 | US20040192676 Ligands of melanocortin receptors and compositions and methods related thereto |
| 09/30/2004 | US20040192657 9-Aminoacyl tetracycline compounds and methods of use thereof |
| 09/30/2004 | US20040192577 Novel sesquiterpene oxides as perfuming and flavoring agents |
| 09/30/2004 | CA2519629A1 Intermediates for the preparation of citalopram and escitalopram |
| 09/30/2004 | CA2519582A1 Substituted p-diaminobenzene derivatives |
| 09/29/2004 | EP1462447A2 Method for the preparation of pure citalopram |
| 09/29/2004 | EP1462436A1 Halogen-containing aromatic compound |
| 09/29/2004 | EP1461332A2 Production of chirally pure alpha-amino acids and n-sulfonyl alpha-amino acids |
| 09/29/2004 | EP1461329A1 Preparation of substituted phthalic anhydrides and substituted phthalimides |
| 09/29/2004 | EP1461315A2 Catalytic carbonylation of three and four membered heterocycles |
| 09/29/2004 | EP1461311A2 Urea derivatives as vr1-antagonists |
| 09/29/2004 | EP1461038A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/29/2004 | EP1461030A1 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma |
| 09/29/2004 | EP1181713B1 Method for the preparation of pure citalopram |
| 09/29/2004 | EP1100483B1 Glucocorticoid-selective anti-inflammatory agents |
| 09/29/2004 | EP1019040B1 Aryl ureas for the treatment of inflammatory or immunomodulatory diseases |
| 09/29/2004 | EP0993439B1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 09/29/2004 | CN1533385A Process for preparation of prostaglandins and analogues thereof |
| 09/29/2004 | CN1533382A 哌嗪衍生物 Piperazine derivatives |
| 09/29/2004 | CN1533372A Process and intermediates to prepare latanoprost |
| 09/29/2004 | CN1533274A Benzofuranes and their use in treatment of artrial fibrillation |
| 09/29/2004 | CN1533270A Oral administered dosage form of GABA anolog prodrugs having reduced toxicity |
| 09/29/2004 | CN1168725C Formulation for protection against oxidative stress containing beozofuranone derivatives |
| 09/29/2004 | CN1168711C Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
| 09/29/2004 | CN1168704C Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide |
| 09/28/2004 | US6797731 Resorcinol derivatives |
| 09/28/2004 | US6797726 N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 09/28/2004 | US6797723 Heterocycle substituted diphenyl leukotriene antagonists |
| 09/28/2004 | US6797713 1,4 substituted piperazines, 1,4 substituted piperidines, and 1-substituted,4-alkylidenyl piperidine compounds; dual acting molecules having both leukotriene inhibition properties |
| 09/28/2004 | US6797712 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain |
| 09/28/2004 | US6797711 Benzofuran derivatives and pharmaceutical compositions containing the same |
| 09/28/2004 | CA2224125C Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 09/23/2004 | WO2004081643A1 Lenslet array with polarization conversion |
| 09/23/2004 | WO2004080996A1 Opioid receptor antagonists |
| 09/23/2004 | WO2004080989A1 Process for production of furan compounds |
| 09/23/2004 | WO2004080988A1 Process for the preparation of a cyano-isobenzofuran |
| 09/23/2004 | WO2004080962A1 2,4,6-phenyl substituted cyclic ketoenols |
| 09/23/2004 | WO2004080947A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 09/23/2004 | WO2004080480A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 09/23/2004 | WO2004080410A2 Furanose-type bicyclic carbohydrates with biological activity |
| 09/23/2004 | WO2004080379A2 Extract of pangium edule and lignanes which can be used as a cathepsin inhibitor or having an antinecrotic effect |
| 09/23/2004 | WO2004080377A2 Kcnq channel modulating compounds and their pharmaceutical use |
| 09/23/2004 | WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same |
| 09/23/2004 | US20040186321 Method for producing ketones from carboxylic acid anhydrides |
| 09/23/2004 | US20040186170 Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient |
| 09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
| 09/23/2004 | US20040186148 E.g., 1-(pyrid-2-yl-so2-),2-((4-(isopropylphenyl)-so2-),5-(isopropoxy)benzene; antiinflammatory agents; immunomodulatory activity rheumatoid arthritis, asthma, allergy, psoriasis, Crohn's disease, systemic lupus erythematosus, multiple sclerosis, diabetes, cancer, glaucoma, osteoporosis, renal ischemia |
| 09/23/2004 | DE10311300A1 New 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols, useful as total or selective herbicides and pesticides, e.g. insecticides, acaricides and nematocides for plant protection |
| 09/23/2004 | CA2518986A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 09/23/2004 | CA2514458A1 Process for the preparation of a cyano-isobenzofuran |
| 09/23/2004 | CA2513791A1 Opioid receptor antagonists |
| 09/22/2004 | EP1458791A1 Methods for the preparation of poly(etherimides)s |
| 09/22/2004 | EP1458724A1 Total synthesis of galanthamine, analogues and derivatives thereof |
| 09/22/2004 | EP1458719A1 Pyridoquinoxaline antivirals |
| 09/22/2004 | EP1458703A1 Isochroman compounds for treatment of cns disorders |
| 09/22/2004 | EP1458701A1 Method for the preparation of escitalopram |
| 09/22/2004 | EP1458700A2 Substituted 2-phenyl benzofurans as estrogenic agents |
| 09/22/2004 | EP1458675A1 Alpha-cyanoacrylates |
| 09/22/2004 | EP1458674A1 Beta-amino-alpha-cyanoacrylates and their use as herbicides |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1343743B1 Method for the production of tetrahydrofuran |
| 09/22/2004 | EP1280788B1 Method for the production of l-ascorbic acid by lactonisation of 2-keto-l-gulonic acid or 2-keto-l-gulonate esters |
| 09/22/2004 | EP1237833B1 Process for the co-production of aliphatic diols and cyclic ethers |
| 09/22/2004 | EP1228056B1 Method for the preparation of citalopram |
| 09/22/2004 | EP1212310B1 Production of maleic anhydride |
| 09/22/2004 | EP1200375B1 Nitration in a static micromixer |
| 09/22/2004 | EP0879231B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 09/22/2004 | CN1531458A Flow reactors for chemical conversions with hetergeneous catalysts |
| 09/22/2004 | CN1531427A Premixed amiodarone parenteral solution and method for making the same |
| 09/22/2004 | CN1167696C Preparation method for butyrolactone |
| 09/21/2004 | US6794545 Conformationally restricted polyamine analogs as disease therapies |
| 09/21/2004 | US6794522 Labeling organic compounds with deuterium and tritium using specific catalysts based on group 8 metals containing pentamethylcyclopentadiene ligand; deuterated tetrahydrofuran or diethyl ether for example |
| 09/21/2004 | US6794408 Central nervous system disorders; alzheimer's diseases; psychological disorders; antidepressants; sleep disorders |
| 09/21/2004 | US6794400 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/21/2004 | US6794397 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/21/2004 | US6794392 Cell differentiation inducer |
| 09/21/2004 | CA2100381C N-derivatives of (phenylethyl-.beta.-ol) amine, a process for their preparation and pharmaceutical compositions containing the same |
| 09/16/2004 | WO2003072553A8 N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials |
| 09/16/2004 | WO2003028729A3 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/16/2004 | US20040181075 Process of making chalcone derivatives |
| 09/16/2004 | US20040181067 Tri(cyclo) substituted amide compounds |
| 09/16/2004 | US20040181058 intermediates for preparing active compounds in medicaments selected from the group consisting of serotonin or noradrenaline uptake inhibitors |
| 09/16/2004 | US20040180964 anti-obestic activity; Neuropeptide Y antagonist |
| 09/16/2004 | US20040180947 Sulfonamide compounds and pharmaceutical use thereof |
| 09/16/2004 | US20040180936 having an inhibitory activity on calpains and/or a trapping activity on reactive oxygen species; inflammatory and immunological diseases; disorders of the central or peripheral nervous system |
| 09/16/2004 | US20040180871 Anti-inflammatory compositions and methods |